{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:03:00Z","timestamp":1781877780201,"version":"3.54.5"},"reference-count":25,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2007,3,9]],"date-time":"2007-03-09T00:00:00Z","timestamp":1173398400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Dermatology"],"published-print":{"date-parts":[[2007,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>Prurigo nodularis is an intensely pruritic dermatosis characterized by lichenified and excoriated papules and nodules. The course of prurigo nodularis is often chronic, and some patients respond very poorly to the standard therapeutic modalities. Because the pathogenesis of this disease remains obscure, the treatment of prurigo nodularis can be disappointing and frustrating for both the patients and physicians. Thalidomide, a tumor necrosis factor\u2010alpha antagonist, has been suggested as an alternative treatment option for recalcitrant prurigo nodularis. In the past, the regimen for treatment of prurigo nodularis often required thalidomide at 200\u00a0mg\/day. We recruited patients with intractable prurigo nodularis and treated them with low\u2010dose thalidomide. Six patients with idiopathic prurigo nodularis were successfully treated with low\u2010dose thalidomide (50\u2013100\u00a0mg\/day) without clinical development of peripheral neuropathy. In summary, our preliminary results suggest that low\u2010dose thalidomide may be a safe and effective treatment option for patients with recalcitrant idiopathic prurigo nodularis.<\/jats:p>","DOI":"10.1111\/j.1346-8138.2007.00260.x","type":"journal-article","created":{"date-parts":[[2007,3,9]],"date-time":"2007-03-09T16:58:14Z","timestamp":1173459494000},"page":"237-242","source":"Crossref","is-referenced-by-count":21,"title":["Treatment of idiopathic prurigo nodularis in Taiwanese patients with low\u2010dose thalidomide"],"prefix":"10.1111","volume":"34","author":[{"given":"Cheng\u2010Che E.","family":"LAN","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi\u2010Ling","family":"LIN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching\u2010Shuang","family":"WU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee\u2010Yin","family":"CHAI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan\u2010Tzu","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwo\u2010Shing","family":"CHEN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2007,3,9]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"129","article-title":"Case of multiple tumor of the skin accompanied by intense pruritus","volume":"6","author":"Hardaway WA","year":"1880","journal-title":"Arch Dermatol"},{"key":"e_1_2_5_3_2","first-page":"174","volume-title":"A Practical Treatise on Diseases of the Skin for the Use of Students and Practitioners.","author":"Hyde JN","year":"1909"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1985.tb02357.x"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0560.1979.tb01161.x"},{"key":"e_1_2_5_6_2","first-page":"215","article-title":"Treatment of prurigo nodularis using thalidomide","volume":"26","author":"Sheskin J","year":"1975","journal-title":"Hautarzt"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00406421"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.173.3.699"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.177.6.1675"},{"key":"e_1_2_5_10_2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.2340\/0001555564412417","article-title":"Thalidomide treatment of prurigo nodularis","volume":"64","author":"Winkelmann RK","year":"1984","journal-title":"Acta Derm Venereol"},{"key":"e_1_2_5_11_2","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archderm.1980.01640290081018","article-title":"Treatment of prurigo nodularis with thalidomide","volume":"116","author":"Van den Broke H","year":"1980","journal-title":"Arch Dermatol"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196212062672305"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt196563303"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(05)70232-1"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1997.00298.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)90122-X"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4362.1984.tb05696.x"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1085-5629(98)80019-9"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70096-9"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(98)70360-3"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-0960.2002.00593.x"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1985.tb02323.x"},{"key":"e_1_2_5_23_2","first-page":"188","article-title":"Use of thalidomide in leprosy","volume":"13","author":"Crawford CL","year":"1994","journal-title":"Adverse Drug React Toxicol Rev"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2002.19502.x"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.1999.00622.x"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.53.37957"}],"container-title":["The Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1346-8138.2007.00260.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1346-8138.2007.00260.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T19:02:32Z","timestamp":1697223752000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1346-8138.2007.00260.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3,9]]},"references-count":25,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["10.1111\/j.1346-8138.2007.00260.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1346-8138.2007.00260.x","archive":["Portico"],"relation":{},"ISSN":["0385-2407","1346-8138"],"issn-type":[{"value":"0385-2407","type":"print"},{"value":"1346-8138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,3,9]]}}}